Figure S1
Plaza-Menacho et al. To test if the temporal sequence of RET kinase autoP was determined by the primary sequence surrounding the different phosphorylation sites, we compared the consensus sequence of RET autoP sites obtained by label-free quantitative mass spectrometry (LFQMS, panel A, B) to the consensus sequence of the optimal RET kinase domain (KD) substrate (panel C) previously identified by peptide arrays (Plaza-Menacho et al., 2011) . This study showed that wild-type (WT) RET KD core preferentially phosphorylates substrates with acidic residues at the position -1
relative to the Y site, together with a combination of acidic and phosphoacceptor residues S and T at positions -2 and -4. This is consistent with a basic RET core KD with a theoretical pI of 8.9. In general, RTKs prefer peptide substrates with a run of acidic residues at positions N-terminal to the tyrosine phosphorylation site and large hydrophobic residues at the Y + 1 and Y + 3 positions (Songyang et al., 1995) . This is also the case for the RET kinase core in principle, but we do not observe a clear preference for large hydrophobic residues at positions +1 and +3. RET autoP sites (Y1062, Y687, Y900, Y905, Y1015, Y1029) show a slight preference for acidic residues E and D at positions -4, -3, -2, however the remaining sequences flanking the phosphorylated tyrosine sites are quite divergent from each other and from an the optimal RET KD core substrate suggesting that primary structure alone does not account for the sequence of autoP. To prove this further, enzymatic assays were performed with the RET ICD in both phosphorylated and non-phosphorylated states against peptides derived from the different phosphorylation sites and the catalytic efficiencies (k cat /K M ) were determined (panel D, E). We observed that: i) enzyme kinetic constants did not follow the same trend observed when RET autoP sites were assessed by LFQMS or WB analysis and ii) phosphorylation status of RET ICD did not change significantly the kinetic constants despite greatly impacting on RET
autoP. These data demonstrate that linear peptides as substrates are poor surrogates and have limited utility to assess determinants of RET kinase autoP. with different rotamers to RET WT. We hypothesize that these differences affect the C-spine and ultimately would indirectly contribute to alter ATP affinity. Further analysis of the two crystal structures presented in this study revealed their close similarity with an overall rmsd of 0.36Å over 290 αC atoms. A closer inspection reveals changes in side chain rotamers for three hydrophobic residues within the RET C-lobe, namely V871, L875 and L923. Both V871 and L875 flank D933 from the αF helix beneath H872 of the regulatory spine. It is unclear from this analysis how to account for the difference in ATP affinity exhibited by the M918T mutant. L923 lies in close proximity to M918 and its side chain rotates towards T918 to partially fill the cavity created by the mutation. We also noticed the adjacent L960 also "flips" its side chain in the M918T structure, in addition to the side chain of L800 within the N-lobe also switches rotamers drawing F709 further into the αC patch, above the αC helix.
Recent work has described kinase activation in terms of the linear alignment of the C-and R-spines (Kornev et al., 2008) . The larger C-spine of RET contains residues emanating from the hydrophobic αF helix, through to nucleotide and capping N-lobe residues (i.e. L940, I944, L812, I880, L881, V882, V738 and A756). The smaller Rspine comprises four residues originating from the αF helix. In RET these residues include H872 (from the catalytic HRD motif), F893 (from the DFG motif defining the start of the activation loop), L779 and L790 (an oncogenic site, i.e. L790F). W717
caps this tetrad and is analogous to W342 found in BRAF required for activation and BRAF dimerization (Hu et al., 2013) . We previously showed that non-phosphorylated RET core kinase domain (PDB code 2IVT) and the phosphorylated form (PDB code 2IVS) have similar structures and activities in solution towards a poly-E 4 Y peptide substrate (Knowles et al., 2006) . In agreement with this, we observe that the R-spine is already assembled in a linear alignment consistent with an active kinase both in solution and in the crystals. Table S1 ATP 
Supplemental experimental procedures
Expression and purification of recombinant proteins.
Protein expression was carried out using Sf9 insect cells as previously described (Knowles et al., 2006) . Human RET ICD (residues 661-1072) and KD core (705-1013) WT and the indicated mutants proteins were purified following a protocol previously described (Knowles et al., 2006) . Briefly, Sf9 insect cells (1-2 x10 Beads were recovered by centrifugation (500 r.p.m., 5 min) and washed five times with elution buffer (20 mM Tris-HCl, 400 mM NaCl and 1mM DTT). Cleavage from glutathione with recombinant 3C-protease was performed overnight rotating at 4 Cº, followed by size exclusion chromatography using a Superdex200 column where indicated.
Mass-spectrometry.
For mass spectrometry, protein samples were separated using pre-cast 4-12% BisTris gels (Invitrogen) and stained using colloidal Coomassie blue (Invitrogen). Protein bands were excised and incubated overnight with destain solution (50 % acetonitrile and 10mM triethylammonium bicarbonate). Bands were washed with destain solution, dehydrated with 100% acetonitrile and vacuum dried, reduced by incubation with 10 mM DTT for 45 min at 50 Cº, alkylated with 50 mM iodoacetamide at room temperature in the dark and then washed three times with destain and dehydrated once more. Proteins were digested at 37 °C overnight using porcine trypsin (Promega, 50 ng/protein band). Proteolysis was stopped by flash freezing before addition of 5% formic acid and sonication for 15 min to extract peptides. The extraction was repeated once prior to sample dehydration. Proteolysed samples were resuspended in 16 µl 1% formic acid for 20 min prior to analysis by nanoreverse phase LC-MS using a QTOF 6520 mass spectrometer with Chip Cube TM source interface and 1200 series HPLC running MassHunter B.04.00 (Agilent, USA).
Samples were loaded onto a chip containing integrated 40 nl enrichment and 150 mm analytical columns and electrospray needle using 3 µl/min 0.1% formic acid.
Peptides were eluted at 300 nl/min using a linear gradient from 10-70% elution buffer (80% acetonitrile/ 20% 0.1% formic acid (v/v)) for 10 min. Within 1 min the gradient was increased to 100% elution buffer and 100% buffer was continued for a further 6 min. Each sample was analyzed twice in data-dependent mode. For this acquisition, MS data was recorded in the 290-2500 m/z range at 6 spectra per second. MS/MS data was acquired in the 57-3000 acquisition mass/charge (m/z) range at 4 spectra per second. All data was acquired in profile mode. The data was searched against UniProt (KB15.5j) and an in-house database containing RET sequences concatenated to UniProt (CRUK_Protein 2011_03 + uniprot_sprot_2011_03) using Mascot Daemon version 2.4.0 (Matrix Science, UK). Search parameters used a peptide tolerance of 10 ppm and a fragment tolerance of 0.05 Da. In addition to statistical scoring, the validity of the data was confirmed by manual curation of the data using Scaffold software 2.1 (Proteome Science, USA).
Mass Spectrometric Label-free Quantitation.
For label-free quantitation three to five biological replicates and three technical replicates were analyzed per condition. Data was acquired using the Agilent's LCChip Cube TM -6510 QTOF in MS only mode. MS data was recorded with the settings described above in profile mode with the exception of recording 1 spectrum per second. Data was acquired randomly as determined by list randomizer (http://www.random.org/lists/). Files were imported into Progenesis LC-MS version 4.0.4573.30654 (Nonlinear Dynamics, UK) for LC-MS run alignment and MS peak extraction for label-free quantitation after ion peak identification by MASCOT. Peaks of interest were analyzed and validated using quantitation workflow set up in Excel.
The RET phosphopeptide normalized abundances from Progenesis LC-MS software were exported to Excel and renormalized against the relative unmodified RET peptides to zero time-point to compensate for loading differences and ensure an accurate representation of relative phosphopeptide abundances. For final quantitation the median log 2 ratio of phosphorylated/unphosphorylated peptides to time 0 min. were determined. The values for related peptides due to enzymatic missed cleavages containing the same phosphorylation sites were averaged.
Statistical analyses were performed across biological replicates (n=3 to 5) using graph pad Prism6.
AutoP assays, SDS-Page and Western blotting (WB).
Unless indicated otherwise, time course autoP assays were performed with recombinant purified RET ICD and/or KD core (2.5 µM) in the presence of saturating concentrations of ATP (5 mM) and MgCl 2 (10 mM) for the indicated time points.
Reactions were stopped by the addition of 4X loading sample buffer (Invitrogen) with 10% β-mercaptoethanol and boiled for 5 min. after which samples were loaded on gel. Samples were run in a NuPAGE Invitrogen 4-12% Bis-Tris precast gels and WB was performed with the indicated antibodies as previously described ( England Biolabs, UK), phospho-Tyr1015 RET (Abcam), phospho-Tyr981 RET (Encinas et al., 2004) , phospho-Tyr687 RET (see below) and total phospho-tyrosine antibody (4G10, Millipore).
Phospho-specific RET Y687 antibody generation.
Polyclonal antisera against phosphorylated RET Y687 was generated by immunizing rabbits with a synthetic peptide (AFPVSpYSSSGA) KLH-conjugated via glutaraldehyde following a standard protocol used (Pettingill Technology Ltd. UK).
Enzymatic kinase assays.
Enzyme kinetic experiments were performed as previously described (Knowles et al., 2006; Plaza-Menacho et al., 2011) . Briefly, rates of phosphorylation by RET kinase were determined using a continuous ADP-coupled kinase assay with the following 
Isothermal Titration Calorimetry (ITC).
Binding of ATP to the RET ICD (WT and the indicated mutants) was performed in an ITC 200 Microcalorimeter (GE Healthcare). The sample cell contained 50 µM of purified recombinant RET intracellular domain, and 1 mM of ATP in the injection syringe to achieve a complete binding isotherm. The buffer for both cell and injection samples was 20 mM Tris pH 7.6, 400 mM NaCl, 10 mM MgCl 2 and 500 µM TCEP.
Injections of 1.5 µl were dispensed with a 5 second addition time and a spacing of 250 seconds, with a total of 15-20 injections. The stirrer speed was set to 1000 r.p.m.
All binding experiments were carried out at 20 °C, with fresh protein samples kept at 4 °C before use. Titration curves were fitted using the MicroCal Origin software, assuming a single binding site mode. Data represent the mean ± SE of 2-3 independent experiments from different protein purifications.
Crystallization, diffraction, data collection and processing.
Crystals of phosphorylated RET KD harboring a M918T mutation were grown at 22
°C by vapor diffusion in sitting drops containing 1.5 µl of protein stock solution (3 mg/ml) mixed with 1 µl of reservoir solution (2.0 M sodium formate and 0.1 M sodium citrate (pH 5.5)), the protein stock solution also contained 2.5 mM ATP and 5 mM MgCl 2 . Crystals were cryoprotected in 50% paratone and flash frozen in liquid nitrogen and X-ray data sets were collected at 100K an in-house MAR image plate detector and a Rigaku MicroMax-007 X-ray goniometer. Data collection and refinement statistics are summarized in Table1. The data set was indexed with MOSFLM and scaled and merged with SCALA (Winn et al., 2011) . Molecular replacement was carried out using the atomic coordinates of the phosphorylated RET KD (PDB code: 2IVT) in MOLREP (Vagin and Teplyakov, 2010) . After positioning the molecule, RESOLVE (Terwilliger, 2000) was used in prime-andswitch mode to reduce phase bias. The structure was refined using Phenix (Adams et al., 2010) and model building was carried out in COOT (Emsley et al., 2010) .
Model validation used PROCHECK (Laskowski and Maryanski, 1993 ) and figures were prepared using the graphic program PYMOL (http:/www.pymol.org).
For the phosphorylated RET KD bound to adenosine structure, crystallization took place in 2.5 µl sitting drops consisting of 1.5:1 (v:v) mixture of 3 mg/ml phosphorylated RET KD with 3 molar excess AMPPNP and well solution containing 0.1 M sodium citrate pH 5.5, and 1.8-2.3 M sodium formate at 20 °C . The crystals took almost 12 months to grow. Cryoprotection was achieved by soaking the crystals for a few min. in 0.1 M sodium citrate pH 5.5, 1.8-2.3 M sodium formate and 25%
glycerol. Crystals were flash-frozen in liquid nitrogen and X-ray data sets were collected at 100K at the I-24 beamline of the Diamond Light Source Synchrotron (Oxford, UK). Data collection and refinement statistics are summarized in Table1.
The data set was indexed with MOSFLM and scaled and merge with SCALA (Winn et al., 2011) . Molecular replacement was carried out in PHASER (McCoy et al., 2007) using the atomic coordinates of the RET KD bound to PP1 inhibitor (PDB ID: 2IVV). The structure was refined using BUSTER (Blanc et al., 2004) and Phenix (Adams et al., 2010) . Model building was carried out in COOT (Emsley et al., 2010) and model validation used PROCHECK (Laskowski and Maryanski, 1993) . Both kinases structures have continuous electron density from Gly700 to Arg1012, (including five N-terminal vector-derived residues), with the exception of kinase insert domain residues 823-843, which are disordered. In both structures RET kinase domain forms a head to tail dimer related by a crystallographic 2-fold axis. The dimer overall arrangement is essentially the same as that found in the phosphorylated RET kinase domain (PDB ID: 2IVT).
Intrinsic Fluorescence (IF).
IF analysis was performed following a similar protocol previously described (Chua et al., 2012) . Briefly, 25 µg of RET ICD WT and the indicated mutants were analyzed using a Tecan Safire 2 plate reader, with an excitation wavelength of 280 nm and emission spectra from 307 to 500 nm using a Corning black 384 wells assay plate.
Data is representative of multiple independent experiments.
Differential Scanning Fluorimetry (DSF).
Thermal denaturation experiments were performed using DSF. Briefly, 5 µg of each protein was added to 90 µl reaction buffer (20 mM Tris-HCl pH 7.65, 400 mM NaCl 
